Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Caplin Laboratories Ltd's Q3 Standalone PAT grows 56%, Consolidated PAT grows 22%

Posted On: 2019-02-11 15:24:08

Caplin Laboratories Ltd (NSE: CAPLIPOINT; BSE Code: 524742), one of the fastest growing mid-cap pharmaceutical companies in India today announced financial results for the Third quarter (Q3FY19) ended December 3l5t, 2018.

Financial Highlights - Standalone Q3 FV19 (YoY%} Review

- Revenue was Rs 1471 mn for Q3FY19 as compared to Rs 1131 mn in the corresponding period of FY18, an increase of 30%.

- EBITDA stood at Rs 565 mn as compared to Rs 392 mn in the corresponding period of FY18, an increase of 44%.

- Net profit was Rs. 369 mn for Q3FY19 as compared to Rs. 236 mn in Q3FY18, an increase of 56%

- Basic EPS stood at Rs 4.88 as against Rs 3.12 in Q3FY18 (growth of 56%).

Consolidated Q3 FY19 (YoY%} Review

- Revenue was Rs. 1667 mn for Q3FY19 as compared to Rs. 1439 mn in the corresponding period of FY18, an increase of 16%.

- EBITDA stood at Rs. 655 mn as compared to Rs. 531 mn during Q3FY18, an increase of 23%

- EBITDA Margin stood at 39% (Increase of 239 bps)

- Net profit was Rs. 458 mn for Q3FY19 as compared to Rs. 375 mn in Q3FY18, an increase of 22%

- Basic EPS was Rs. 6.06 as against Rs. 4.97 in Q3FY18 (growth of 22%)

Standalone 9 months ended December 2018 Review

- Revenue was Rs. 4282 mn upto Q3FY19 as compared to Rs. 3364 mn in the corresponding period of FY18, an increase of 27%.

- EBITDA stood at Rs. 1641 mn as compared to Rs. 1272 mn in the corresponding period of FY18, an increase of 29%.

- Net profit was Rs. 1078 mn for Q3FY19 as compared to Rs. 807 mn in Q3FY18, an increase of 34%

- Basic EPS stood at Rs 14.26 as against Rs 10.68 in Q3FY18 (growth of 34%).

Consolidated 9 months ended December 2018 Review

- Revenue was Rs. 4777 mn upto Q3FY19 as compared to Rs. 4062 mn in the corresponding period of FY18, an increase of 18%.

- EBITDA stood at Rs. 1829 mn as compared to Rs. 1558 mn during Q3FY18, an increase of 17%

- EBITDA Margin stood at 38%

- Net profit was Rs. 1267 mn for Q3FY19 as compared to Rs. 1093 mn in Q3FY18, an increase of 16%

- Basic EPS was Rs. 16.77 as against Rs. 14.48 in Q3FY18 (growth of 16%}

Commenting on the performance Dr. Sridhar Ganesan, Managing Director of the Company said "We have again shown strong growth in terms of Top and Bottom Line this Quarter, compared to the same period of the previous financial year. Our Standalone growth has been commendable due in part to milestone payments we have received from a couple of filed ANDAs in the US. Our EBITDA/PA T numbers remains at a high level as usual.

Our target is to file 3 more ANDAs before the end of this FY, taking the tally to 11 ANDAs filed from Caplin, with 3 approvals already received. We also had a major development recently where we have moved our Injectable plant and other assets for US market into our subsidiary 'Caplin Steriles Ltd' where we have attracted investment from a globally renowned player - Fidelity's investment arms Eight Roads and F-Prime Capital.

China remains high on our priority and we're putting together a business model that will be sustainable and create value for all stakeholders in the medium to long term."

Shares of CAPLIN POINT LABORATORIES LTD. was last trading in BSE at Rs.358.9 as compared to the previous close of Rs. 361.55. The total number of shares traded during the day was 693 in over 44 trades.

The stock hit an intraday high of Rs. 359.7 and intraday low of 351. The net turnover during the day was Rs. 246036.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Majesco announces ready-to-use partner apps in Majesco Digital1st EcoExchange™

Timex appoints Ajay Dhyani as the Head Marketing

Bajaj Finance Ltd launches five digitally-enabled Fixed Deposit service branches in Pune

Alankit collaborates with MCGM to provide e-Governance services to one crore citizens

Bank of Maharashtra board to announce Q4, FY19 results on April 29, 2019

Jay Bharat Maruti Ltd FY 2018-19 net profit slides to Rs. 52.17 crores

ADIA and NIIF to invest in GVK's airports holding company

Godrej Properties Ltd board to consider Q4, FY19 results, fund raising on April 30, 2019

Visaka Industries Ltd board to approve Q4, FY19 results on May 3, 2019

Chambal Fertilisers & Chemicals Ltd board to announce Q4, FY19 results on May 16, 2019

Reliance Industries Ltd Board recommends Dividend of Rs. 6.50 for 2018-19

Commercial Syn Bags Ltd receives in-principle approval for migration to main board of BSE

Jay Bharat Maruti Ltd Board approves Dividend of Rs. 2.50 for 2018-19

ICICI Lombard General Insurance Company Ltd - Financial Highlights for Q4, FY 2018-19

Majestic Auto Ltd posts Q4 FY19 net profit of Rs. 20.04 crores

ICICI Lombard General Insurance Company Ltd Board approves Dividend of Rs. 3.50

SBI board to consider raising $2.5 bn

Reliance Industries Ltd has reported consolidated PAT of Rs. 39837 crores in FY 2018-19

Tata Sponge Iron Ltd to change name as Tata Steel Long Products Ltd

Zensar announces sponsorship of the International Women's Hackathon 2019

Cyient and lndia 2022 Coalition Launch MedTechConnect Platform

CARE assigns rating to K P I Global Infrastructure Ltd

Tech Mahindra Ltd board to consider Q4, FY19 results, dividend on May 21, 2019

Tata Sponge Iron Ltd Board recommends Dividend of Rs. 12.50 for 2018-19

Piramal Enterprises Ltd Board to consider FY19 results & Dividend on April 26, 2019

Hindustan Foods Ltd approves proposal to acquire 8.46% in ATC Beverages Pvt Ltd

Bandhan Bank Ltd board to consider Q4, FY19 results, dividend on May 2, 2019

TATA Sponge Iron Ltd posts consolidated PAT of Rs. 124.34 crores in FY 2018-19

DCB Bank Ltd Board recommends Dividend of Rs. 1 for 2018-19

Tamboli Capital Ltd Board to consider Dividend on May 11, 2019

DCB Bank Ltd - Financial Highlights for FY 2019

K P Energy Ltd awarded ISO certifications

CRISIL downgrades rating of Technofab Engineering Ltd

DCB Bank Ltd FY19 PAT soars to Rs. 325.37 crores

AMAL Ltd posts Q4 net profit of Rs. 3.40 crores in Q4 FY19

Financial Highlights of RBL Bank Limited

RBL Bank Ltd Board approves Dividend of Rs. 2.70

HCL Technologies partners with Google Cloud to enable hybrid cloud services for enterprises and ISVs

RBL Bank Ltd reports consolidated net profit of Rs. 857.83 crores for FY 2018-19

Investment & Precision Castings Ltd board to consider Q4, FY19 results, dividend on April 29, 2019

Schaeffler India Ltd board to announce quarterly results on April 30, 2019

Tata Steel Ltd Board to consider FY19 results & Dividend on April 25, 2019

Mahindra and Ford sign agreement to co-develop a midsize SUV

Orient Electric gets 'Superbrand 2019' status for fans and air coolers

SpiceJet to add six more Boeing 737s

L&T Heavy Engineering bags significant contracts

Ambuja Cements Ltd board to consider Q1 CY19 results on April 30, 2019

VST Industries Ltd board to announce dividend, FY19 results on May 3, 2019

Granules Pharmaceuticals inc. received US WA approval for Acetaminophen 650 mg, Extended Release Tablet

Indiabulls Integrated Services Ltd arm receives R1 approval for General Insurance Business







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019